Johnson & Johnson (JNJ.N: Quote, Profile, Research) on Wednesday said U.S. regulators had approved use of the company's Remicade arthritis drug to treat severe adult psoriasis, raised skin lesions caused by inflammation.

« European Court of First Instance (CFI): Commission must revisit its competition ruling against GSK | Main | Adeza Biomedical "Update from UBS Life Sciences Conference" (Buy 1) Ulrich »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341cce4453ef00d83534a2bc53ef
Listed below are links to weblogs that reference Remicade - J&J arthritis drug approved for psoriasis: